Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Conduent, Inc. (CNDT)
NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
$1.64-0.61%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for CNDT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Generate positive cash flow from operations | Cash flow from operations showed sharp gains in late 2025. | Broken | Cash flow remains negative or declines further | Cash from operations: $7M FY2026-Q2; GAAP. Published target: Cash from operations >= $0. Target period is not explicitly aligned with this observation. Aug 10, 20267,000,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk turnaround thesis, not a proven durable growth story. The thesis is in a watch state, with fragile earnings quality and volatile management signals; recent performance is neutral, but the overall signal has become more cautious.
The evidence snapshot gives no valuation or market-expectations data, so whether CNDT looks cheap, fair, or expensive versus peers is unclear. The available evidence does not show what the market already assumes about a recovery.
Near term, results have been mixed: revenue declined from $723 million in Q1 2026 to $531 million in Q2, and adjusted EBITDA declined from $49 million to $16 million. Management has cited cost savings, but delivery remains limited, and new business signings also fell quarter to quarter; the company missed its most recent quarter, while a guidance cut on the next call is a stated risk.
Over the next one to three years, the thesis hinges on whether cost reductions improve operating performance and pipeline converts into profitable growth. A further guidance cut would weaken the case, while rate cuts or stabilization among major technology peers could support the sector backdrop, but would not replace the need for company-level progress.
CNDT remains a cautious, high-risk turnaround story, with limited evidence so far that management priorities are translating into stronger results. The multi-year view depends on sustained improvement in profitability and sales conversion. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Operating losses improved from -$38M to -$27M. |
| Broken |
| Operating loss worsens or stays below -$27M |
Operating income: $-44M FY2026-Q2; GAAP. Published target: Operating loss improves from -$27M toward zero. Target period is not explicitly aligned with this observation. Aug 10, 2026-44,000,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “We are simplifying the organization, strengthening financial discipline and taking structural costs out of the business, while making good progress against our approximately $100 million annualized cost-savings program.” “Q2 2026 Adjusted EBITDA of $16 million and Adjusted EBITDA margin of 3.0% decreased, respectively, versus the prior year, due to lower profitability in our Government segment.” Delivery assessment Nov 4, 2026 |
Achieve full-year 2026 revenue between $2.8B and $2.9B | A primary condition in Conduent, Inc.'s published investment case. The stated target is >=2800 USD_MILLIONS. | Broken | Revenue falls below $2.8B in 2026 | Revenue: $531M FY2026-Q2; GAAP. Published target: >=2800 USD_MILLIONS. Target period ends 2026-12-31; this observation covers 2026-Q2. Aug 10, 2026531,000,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.20 → $-0.01 · observed estimates
$2.57B → $2.21B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.20 | $2,573,650,000 | 1 / 2 |
| 2026-07-25 | $-0.20 | $2,573,650,000 | 1 / 2 |
| 2026-07-26 | $-0.20 | $2,573,650,000 | 1 / 2 |
| 2026-07-27 | $-0.20 | $2,573,650,000 | 1 / 2 |
| 2026-07-28 | $-0.20 | $2,573,650,000 | 1 / 2 |
| 2026-07-29 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-07-30 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-07-31 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-01 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-02 | $-0.20 | $2,573,650,000 | 1 / 2 |
| 2026-08-03 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-04 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-05 | $-0.20 | $2,573,650,000 | 1 / 2 |
| 2026-08-06 | $-0.20 | $2,573,650,000 | 1 / 2 |
| 2026-08-07 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-08 | $-0.20 | $2,573,500,000 | 1 / 2 |
| 2026-08-09 | $-0.20 | $2,573,500,000 | 1 / 2 |
| 2026-08-10 | $-0.20 | $2,573,500,000 | 1 / 2 |
| 2026-08-11 | $-0.20 | $2,573,500,000 | 1 / 2 |
| 2026-08-12 | $0.02 | $2,218,000,000 | 1 / 1 |
| 2026-08-13 | $0.02 | $2,218,000,000 | 1 / 1 |
| 2026-08-14 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-15 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-16 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-17 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-18 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-19 | $-0.05 | $2,698,000,000 | 1 / 2 |
| 2026-08-20 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-21 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-22 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-23 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-24 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-25 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-26 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-27 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-28 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-29 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-30 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-08-31 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-01 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-02 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-03 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-04 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-05 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-06 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-07 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-08 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-09 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-10 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-11 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-12 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-13 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-14 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-15 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-16 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-17 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-18 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-19 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-20 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-21 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-22 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-23 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-24 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-25 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-26 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-27 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-28 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-29 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-09-30 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-10-01 | $-0.05 | $2,259,000,000 | 1 / 2 |
| 2026-10-02 | $-0.03 | $2,239,666,667 | 1 / 1 |
| 2026-10-03 | $-0.03 | $2,239,666,667 | 1 / 1 |
| 2026-10-04 | $-0.01 | $2,239,666,667 | 1 / 2 |
| 2026-10-05 | $-0.01 | $2,239,666,667 | 1 / 2 |
| 2026-10-06 | $-0.01 | $2,239,666,667 | 1 / 2 |
| 2026-10-07 | $-0.01 | $2,239,666,667 | 1 / 2 |
| 2026-10-08 | $0.00 | $2,210,666,667 | 1 / 2 |
| 2026-10-09 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-10 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-11 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-12 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-13 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-14 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-15 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-16 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-17 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-18 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-19 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-20 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-21 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-22 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-23 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-24 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-25 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-26 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-27 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-28 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-29 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-30 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-10-31 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-11-01 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-11-02 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-11-03 | $-0.01 | $2,210,666,667 | 1 / 2 |
| 2026-11-04 | $-0.01 | $2,210,666,667 | 1 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.